Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00418639
Status:
COMPLETED
Last Update Posted:
2007-01-05
First Post:
2007-01-03
Brief Title:
Study of Nitazoxanide in the Treatment of Chronic Hepatitis C
Sponsor:
Romark Laboratories LC
Organization:
Romark Laboratories LC
Study Overview
Official Title:
Randomized Double-Blind Placebo-Controlled Study of Nitazoxanide in the Treatment of Chronic Hepatitis C
Status:
COMPLETED
Status Verified Date:
2007-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the effect of treatment with 24 weeks nitazoxanide monotherapy on end of treatment virologic response sustained virologic response reduction of quantitative serum HCV RNA changes in ALT and safety parameters
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None